Agilent Technologies Inc. has named Roeland G.W. Verhaak, of the Jackson Laboratory (JAX), the winner of the company’s Early Career Professor Award. Verhaak was selected for his contributions to the implementation of transcriptomics, genomics, and big-data analysis to the classification and diagnosis of various cancer types.
Agilent Technologies Inc. has named Roeland G.W. Verhaak, of the Jackson Laboratory (JAX), the winner of the company’s Early Career Professor Award. Verhaak was selected for his contributions to the implementation of transcriptomics, genomics, and big-data analysis to the classification and diagnosis of various cancer types.
“Agilent is pleased to recognize Dr. Verhaak with this award and to support his important research at JAX,” said Jack Wenstrand, Agilent’s director of university relations and external research.
“Dr. Verhaak is recognized internationally for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches. His data-driven, unbiased analyses of cancer genomics and profound understanding of cancer biology are improving our ability to identify clinically relevant subtypes of cancer,” continued Wenstrand.
Established in 2008, the Agilent Early Career Professor Award seeks to recognize the achievements of academic researchers in the early stages of their careers and to establish strong collaborative relationships.
“We’re so pleased that Dr. Verhaak has received this prestigious award in recognition of his outstanding work in advancing human health,” said Charles Lee, Ph.D., FACMG, scientific director and professor at JAX Genomic Medicine.
For more information, please visit: www.agilent.com/about/newsroom/presrel/2016/18oct-ca16031.html
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.